Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.-Reference-Cited by-同舟云学术

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

Published:1982-09 Issue:3 Volume:14 Page:347-355
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Millar JA,Derkx FH,McLean K,Reid JL

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1982.tb01990.x/fullpdf

Reference34 articles.

1. The effects of the antagonists of the renin-angiotensin system on cardiovascular response to lowerbody subatmospheric pressure in the anaesthetised cat.;ADIGUN;Clin. Sci.,1980

2. An international collaborative of renin assay: Establishment of the international reference preparation of human renin.;BANGHAM;Clin. Sci. mol. Med.,1975

3. Three new long-acting converting enzyme inhibitors: Relationship between plasma converting enzyn: activity and response to angiotensin I.;BIOLLAZ;Clin. Pharmac. Ther.,1981

4. Opposite effects of captopril on angiotensin I converting enzyme ‘activity’ and ‘concentration’, relation between enzyme inhibition and long term blood pressure response.;BOOMSMA;Clin. Sci.,1981

5. Effect of a new angiotensin converting enzyme inhibitor MK421 and its lysine analogue on the components of the renin system in healthy subjects.;BRUNNER;Br. J. clin. Pharmac.,1981

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostic Radiopeptides in Nuclear Oncology: Design, Preclinical Screening, and Clinical Translation;Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum;2024

2. Optimizing the Profile of [99mTc]Tc–NT(7–13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors;International Journal of Molecular Sciences;2020-10-26

3. Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands;Pharmaceutics;2020-06-09

4. Applications of biomarkers for different purposes in drug development;Biomarkers, Diagnostics and Precision Medicine in the Drug Industry;2019

5. Principales componentes del sistema renina-angiotensina-aldosterona: historia, modulación farmacológica e impacto clínico;Revista Médica Clínica Las Condes;2010-07